These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38789905)

  • 1. Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens.
    Algburi AR; Jassim SM; Popov IV; Weeks R; Chikindas ML
    Braz J Microbiol; 2024 Sep; 55(3):2581-2592. PubMed ID: 38789905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteria competing with the adhesion and biofilm formation by Staphylococcus aureus.
    Sadowska B; Walencka E; Wieckowska-Szakiel M; Różalska B
    Folia Microbiol (Praha); 2010 Sep; 55(5):497-501. PubMed ID: 20941586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
    Weldrick PJ; Hardman MJ; Paunov VN
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
    Gupta S; Agarwal S; Sahoo DR; Muralidharan S
    Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic 9,10-Dehydrofukinone Action on Pathogenic and Non-Pathogenic Bacterial Biofilms. Why Is This Main Volatile Metabolite in Senecio?
    Verni MC; Garay JA; Mendoza L; Bardón A; Borkosky S; Arena ME; Cartagena E
    Chem Biodivers; 2020 Jun; 17(6):e1900507. PubMed ID: 32277597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study.
    Kaur S; Sharma P
    Probiotics Antimicrob Proteins; 2015 Jun; 7(2):172-80. PubMed ID: 25693845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
    Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of probiotics isolated from dietary supplements and evaluation of metabiotic-antibiotic combinations as promising therapeutic options against antibiotic-resistant pathogens using time-kill assay.
    El Far MS; Zakaria AS; Kassem MA; Edward EA
    BMC Complement Med Ther; 2024 Aug; 24(1):303. PubMed ID: 39143578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm Formation by Lactobacillus Strains of Modern Probiotics and Their Antagonistic Activity against Opportunistic Bacteria.
    Svitich OA; Poddubikov AV; Vartanova NO; Leonova AY; Kurbatova EA
    Bull Exp Biol Med; 2024 Aug; 177(4):476-481. PubMed ID: 39264564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections.
    Affhan S; Dachang W; Xin Y; Shang D
    Genet Mol Res; 2015 Dec; 14(4):17044-58. PubMed ID: 26681052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients.
    Pompilio A; Kaya E; Lupetti V; Catelli E; Bianchi M; Maisetta G; Esin S; Di Bonaventura G; Batoni G
    Microbes Infect; 2024; 26(4):105301. PubMed ID: 38237656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cell-free supernatant of
    Koohestani M; Moradi M; Tajik H; Badali A
    Vet Res Forum; 2018; 9(4):301-306. PubMed ID: 30713607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
    Belfield K; Bayston R; Hajduk N; Levell G; Birchall JP; Daniel M
    J Antimicrob Chemother; 2017 Sep; 72(9):2531-2538. PubMed ID: 28859444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chlorogenic acid and carnosol for anti-efflux pump and anti-biofilm activities against extensively drug-resistant strains of
    Sheikhy M; Karbasizade V; Ghanadian M; Fazeli H
    Microbiol Spectr; 2024 Sep; 12(9):e0393423. PubMed ID: 39046262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells.
    Nami Y; Abdullah N; Haghshenas B; Radiah D; Rosli R; Khosroushahi AY
    Anaerobe; 2014 Aug; 28():29-36. PubMed ID: 24818631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of multiple candidate probiotic bacteria reveals specificity in the ability to modify the effects of key wound pathogens.
    Alhubail M; McBain AJ; O'Neill CA
    Microbiol Spectr; 2024 Jun; 12(6):e0034724. PubMed ID: 38700333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
    Chen X; Thomsen TR; Winkler H; Xu Y
    BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
    Algburi A; Alazzawi SA; Al-Ezzy AIA; Weeks R; Chistyakov V; Chikindas ML
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
    Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
    Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.